GTX-011 (GAT Therapeutics)

N/A

Report date: 2025/01/10 14:24:14
NME

Base Information

Drug NameGTX-011 (GAT Therapeutics)
Drug Alias NameGTX-011 (GAT Therapeutics)GTX-11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor modulatorsTGF-β pathway modulators
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPrimary MyelofibrosisPulmonary FibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGAT Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesGAT Therapeutics SL
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisPulmonary FibrosisLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A